The February issue of Health Level Seven International (HL7) News highlights Telligen and MCG’s work on interoperability for prior authorization. The feature, written by Srinivas Velamuri, enterprise architect at Telligen, goes over Telligen’s partnership with MCG to provide evidence-based clinical criteria to help automate the authorization process and implement HL7’s Da Vinci PAS. Velamuri covers the milestones of the interoperability project, the challenges to adoption, future enhancements to the project, and more.
HL7 is a non-profit organization responsible for the development of interoperability standards such as FHIR. You can read the feature on Telligen’s project by downloading the article here (PDF) or by visiting the HL7 website.